Cargando…
Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
SHP2 mediates signaling from multiple receptor tyrosine kinases (RTKs) to extracellular signal-regulated kinase (ERK) and Ser and Thr kinase AKT, and its inhibitors offer an unprecedented opportunity for cancer treatment. Although the ERK signaling variation after SHP2 inhibition has been well inves...
Autores principales: | Li, Ye, Yuan, Yuncang, Zhang, Fan, Guo, Aizhen, Cao, Fuao, Song, Mengmeng, Fu, Yating, Xu, Xiaowen, Shen, Hao, Zheng, Shangyong, Pan, Yamin, Chang, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591248/ https://www.ncbi.nlm.nih.gov/pubmed/34790119 http://dx.doi.org/10.3389/fphar.2021.739501 |
Ejemplares similares
-
SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
por: Zhang, Linxi, et al.
Publicado: (2022) -
SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer
por: Huang, Yan, et al.
Publicado: (2017) -
Eyes absent homologue 2 predicts a favorable prognosis in colorectal cancer
por: Zheng, Jie, et al.
Publicado: (2018) -
High expression of phosphorylated focal adhesion kinase predicts a poor prognosis in human colorectal cancer
por: Yu, Guanyu, et al.
Publicado: (2022) -
Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer
por: Xie, Zhongdong, et al.
Publicado: (2017)